GENEVA, July 18 -- DANA-FARBER CANCER INSTITUTE, INC. filed a patent application (US2025/053913) for “GENOMIC PROFILING OF CELLS TO MONITOR MINIMUM RESIDUAL DISEASE”. With publication no. WO/2026/097062, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: C12Q 1/6886
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....